# DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

> **NCT01752894** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 776 (actual)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DEVICE:** Angio-guided PCI with EES or BES
- **DEVICE:** OCT-guided PCI with EES or BES
- **DEVICE:** PCI with BES under angio-guide or OCT guide
- **DEVICE:** PCI with EES under angio-guide or OCT guide
- **DRUG:** Keep DAPT
- **DRUG:** Discontinue DAPT

## Key facts

- **NCT ID:** NCT01752894
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-02
- **Primary completion:** 2017-04-11
- **Final completion:** 2017-04-11
- **Target enrollment:** 776 (ACTUAL)
- **Last updated:** 2019-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752894, "DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01752894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*